Jessica M Gannon, MD

Associate Professor of Psychiatry

Areas of Expertise

  • Psychosis
Jessica M Gannon, MD
Expertise & Interests Selected Publications Education & Credentials Related News

Expertise & Interests

Research Interests

Psychotherapy and schizophrenia; Predictive models of treatment response; Adjunctive psychopharmacology; schizophrenia

Clinical Interests

Schizophrenia spectrum disorders; Evidence-based psychotherapy for schizophrenia; Clinical informatics

Education Interests

Resident education; Physician well being; Electronic medical records

Selected Publications

  1. Gannon JM, Sanchez M, Lines K, Cairns K, Reardon C, Chengappa KNR, Calkin CV. Predicting conversion to insulin sensitivity with Metformin: A promising tool for clinicians in addressing insulin resistance and improving outcomes in patients with treatment resistant bipolar depression. J Clin Psychopharmacol. 2024 Mar-Apr 01;44(2):157-160. doi: 10.1097/JCP.0000000000001818. PMID: 38421924.
  2. Panchal Y, Gannon JM (co-first author), Tatar JM, Balasubramani GK. COVID-19 vaccination among patients with schizophrenia prescribed clozapine. Schizophr Res. 2023 Sep 8;261:31-33. doi: 10.1016/j.schres.2023.09.005. Epub ahead of print. PMID: 37690168.
  3. Gannon J, Brar JS, Zawacki S, Painter T, OToole K, Chengappa KNR. From office-based treatment to telehealth: Comparing clinical outcomes and patient participation in a psychiatric intensive outpatient program with a large transdiagnostic sample. Telemed J E Health. 2021 Dec 29. doi: 10.1089/tmj.2021.0421. Epub ahead of print. PMID: 34964653.
  4. Gannon JM, Lupu A, Brar JS, Brandt M, John S, Carl K, Chengappa KNR. Deprescribing anticholinergic medication in the community mental health setting: A quality improvement initiative. Res Social Adm Pharm. 2021 Oct;17(10):1841-1846. PMID: 33357980.
  5. Gannon, J. M., Forrest, P. E., & Chengappa, K. R. (2014). Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder. Journal of Ayurveda and integrative medicine, 5(4), 241.
  6. Gannon JM, Chengappa KNR, Cotes RO, Leung JG, Piechowicz M, Kistler E, Nathaniel V, Eldredge C, Alessandro J, Clinebell K, Yabs M, Adair D, Zimmerman J. Innovative Practice: A model for timely dissemination of critical information Clozapine toxicity during the COVID pandemic. Ment Health Clin. In press.
  7. Gannon JM. Three recommendations for addressing the ongoing lithium underutilization crisis in bipolar disorder. Bipolar Disord. 2020 Apr 18; 00:12. PMID: 32304620
  8. Chengappa KN, Gannon JM, Acharya L, Rai A (2017). The potential utility of ashwagandha for improving cognitive dysfunction in persons with bipolar or other neurocognitive disorders. In: Kaul S, Wadhwa R, editors. Science of Ashwagandha: Preventive and Therapeutic Potential. Springer International Publishing.
  9. Hudak R, Gannon JM. Handbook of Psychiatric Disorders in Adults in the Primary Care Setting. Springer International Publishing; 2022. 218 p.
  10. Wilkening GL, Gannon JM, Ross C, Brennan JL, Fabian TJ, Marcsisin MJ & Benedict NJ. (2016). Evaluation of Branched-Narrative Virtual Patients for Interprofessional Education of Psychiatry Residents. Academic Psychiatry, 1-5.
  11. Marcsisin, MJ, Rosenstock JB & Gannon JM. (2016). Schizophrenia and Related Disorders. Oxford University Press.

Education & Credentials

Education & Training

Education
MD, University of Kansas, School of Medicine
Residency
Psychiatry, Western Psychiatric Institute and Clinic of UPMC
Fellowship
Electroconvulsive Therapy, Western Psychiatric Institute and Clinic of UPMC

Professional Affiliations

  • Member, American Psychiatric Association

Related News